269 related articles for article (PubMed ID: 11891184)
21. Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features.
Xie D; Nakachi K; Wang H; Elashoff R; Koeffler HP
Cancer Res; 2001 Dec; 61(24):8917-23. PubMed ID: 11751417
[TBL] [Abstract][Full Text] [Related]
22. Decreased expression of the angiogenic regulators CYR61 (CCN1) and NOV (CCN3) in human placenta is associated with pre-eclampsia.
Gellhaus A; Schmidt M; Dunk C; Lye SJ; Kimmig R; Winterhager E
Mol Hum Reprod; 2006 Jun; 12(6):389-99. PubMed ID: 16675545
[TBL] [Abstract][Full Text] [Related]
23. Muscarinic acetylcholine receptors induce the expression of the immediate early growth regulatory gene CYR61.
Albrecht C; von Der Kammer H; Mayhaus M; Klaudiny J; Schweizer M; Nitsch RM
J Biol Chem; 2000 Sep; 275(37):28929-36. PubMed ID: 10852911
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of CCN1/CYR61, CCN3/NOV, CCN4/WISP1, and CCN5/WISP2 in neurofibromatosis type 1 tumorigenesis.
Pasmant E; Ortonne N; Rittié L; Laurendeau I; Lévy P; Lazar V; Parfait B; Leroy K; Dessen P; Valeyrie-Allanore L; Perbal B; Wolkenstein P; Vidaud M; Vidaud D; Bièche I
J Neuropathol Exp Neurol; 2010 Jan; 69(1):60-9. PubMed ID: 20010302
[TBL] [Abstract][Full Text] [Related]
25. Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma.
Bennani-Baiti IM; Machado I; Llombart-Bosch A; Kovar H
Hum Pathol; 2012 Aug; 43(8):1300-7. PubMed ID: 22245111
[TBL] [Abstract][Full Text] [Related]
26. The nephroblastoma overexpressed gene (NOV/ccn3) protein associates with Notch1 extracellular domain and inhibits myoblast differentiation via Notch signaling pathway.
Sakamoto K; Yamaguchi S; Ando R; Miyawaki A; Kabasawa Y; Takagi M; Li CL; Perbal B; Katsube K
J Biol Chem; 2002 Aug; 277(33):29399-405. PubMed ID: 12050162
[TBL] [Abstract][Full Text] [Related]
27. Proposal for a unified CCN nomenclature.
Brigstock DR; Goldschmeding R; Katsube KI; Lam SC; Lau LF; Lyons K; Naus C; Perbal B; Riser B; Takigawa M; Yeger H
Mol Pathol; 2003 Apr; 56(2):127-8. PubMed ID: 12665631
[TBL] [Abstract][Full Text] [Related]
28. Dose-dependent differential upregulation of CCN1/Cyr61 and CCN3/NOV by the gap junction protein Connexin43 in glioma cells.
Sin WC; Bechberger JF; Rushlow WJ; Naus CC
J Cell Biochem; 2008 Apr; 103(6):1772-82. PubMed ID: 18004727
[TBL] [Abstract][Full Text] [Related]
29. The CCN3 protein and cancer.
Perbal B
Adv Exp Med Biol; 2006; 587():23-40. PubMed ID: 17163153
[TBL] [Abstract][Full Text] [Related]
30. Expressions of cysteine-rich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance.
Zeng ZJ; Yang LY; Ding X; Wang W
World J Gastroenterol; 2004 Dec; 10(23):3414-8. PubMed ID: 15526358
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells.
Croci S; Landuzzi L; Astolfi A; Nicoletti G; Rosolen A; Sartori F; Follo MY; Oliver N; De Giovanni C; Nanni P; Lollini PL
Cancer Res; 2004 Mar; 64(5):1730-6. PubMed ID: 14996733
[TBL] [Abstract][Full Text] [Related]
32. Genomic structure and chromosomal mapping of the mouse nov gene.
Snaith MR; Natarajan D; Taylor LB; Choi CP; Martinerie C; Perbal B; Schofield PN; Boulter CA
Genomics; 1996 Dec; 38(3):425-8. PubMed ID: 8975721
[TBL] [Abstract][Full Text] [Related]
33. The aminoterminal insulin-like growth factor (IGF) binding domain of IGF binding protein-3 cannot be functionally substituted by the structurally homologous domain of CCN3.
Yan X; Baxter RC; Perbal B; Firth SM
Endocrinology; 2006 Nov; 147(11):5268-74. PubMed ID: 16935848
[TBL] [Abstract][Full Text] [Related]
34. Altered expression of novH is associated with human adrenocortical tumorigenesis.
Martinerie C; Gicquel C; Louvel A; Laurent M; Schofield PN; Le Bouc Y
J Clin Endocrinol Metab; 2001 Aug; 86(8):3929-40. PubMed ID: 11502835
[TBL] [Abstract][Full Text] [Related]
35. Nuclear addressing provides a clue for the transforming activity of amino-truncated CCN3 proteins.
Planque N; Long Li C; Saule S; Bleau AM; Perbal B
J Cell Biochem; 2006 Sep; 99(1):105-16. PubMed ID: 16598765
[TBL] [Abstract][Full Text] [Related]
36. Oxidative phosphorylation dysfunction modulates expression of extracellular matrix--remodeling genes and invasion.
van Waveren C; Sun Y; Cheung HS; Moraes CT
Carcinogenesis; 2006 Mar; 27(3):409-18. PubMed ID: 16221732
[TBL] [Abstract][Full Text] [Related]
37. [Genetic alterations associated with pathologic differentiation of Wilms' tumors].
Chevalier G; Perbal B
Bull Cancer; 1997 Mar; 84(3):289-303. PubMed ID: 9207876
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of CCN family members CYR611, CTGF and NOV in gastric cancer and their association with disease progression.
Li J; Gao X; Ji K; Sanders AJ; Zhang Z; Jiang WG; Ji J; Ye L
Oncol Rep; 2016 Nov; 36(5):2517-2525. PubMed ID: 27633176
[TBL] [Abstract][Full Text] [Related]
39. The CCN family: a new stimulus package.
Brigstock DR
J Endocrinol; 2003 Aug; 178(2):169-75. PubMed ID: 12904165
[TBL] [Abstract][Full Text] [Related]
40. The CCN3 (NOV) cell growth regulator: a new tool for molecular medicine.
Perbal B
Expert Rev Mol Diagn; 2003 Sep; 3(5):597-604. PubMed ID: 14510180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
